{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014240","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2025-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.546706+00:00","generated_at":"2026-05-17T06:06:59.243294+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Insight Molecular Diagnostics raises CEO salary to $520K and CFO to $441K","bullets":["CEO Joshua Riggs base salary increased from $420,000 to $520,000, effective Sept 15, 2025.","CFO Andrea James base salary increased from $341,250 to $441,250, effective same date.","Increases approved by Board and Compensation Committee on September 16, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014240","json":"https://secwatch.observer/filing/0001493152-25-014240.json","markdown":"https://secwatch.observer/filing/0001493152-25-014240.md","text":"https://secwatch.observer/filing/0001493152-25-014240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225014240/0001493152-25-014240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315225014240/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:06:59.243294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}